Tech Company Financing Transactions
TAI Diagnostics Funding Round
United Therapeutics participated in a $10 million Series A funding round for TAI Diagnostics. The round closed on 1/10/2018.
Transaction Overview
Company Name
Announced On
1/10/2018
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
United Therapeutics (Paul Mahon)
Proceeds Purpose
The proceeds of this financing will support on-going research and development of TAI's innovative cell-free DNA (cfDNA) transplant monitoring technology, clinical studies, and the upcoming commercial launch of its post-transplant monitoring assays performed by its CLIA and CAP accredited reference laboratory.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10101 Innovation Drive 600
Wauwatosa, WI 53226
USA
Wauwatosa, WI 53226
USA
Phone
Website
Email Address
Overview
TAI Diagnostics, Inc. operates in the biotechnology sector. The company was founded in 2013 and is based in Wauwatosa, Wisconsin.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Mitchell
Vice President
Aoy Mitchell
Browse more venture capital transactions:
Prev: 1/10/2018: FoodMaven venture capital transaction
Next: 1/10/2018: Adapsyn Bioscience venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs